Nektar Therapeutics (NKTR)
1.38
-0.04
(-2.82%)
USD |
NASDAQ |
Apr 24, 16:00
1.39
+0.01
(+0.72%)
After-Hours: 20:00
Nektar Therapeutics Price to Book Value: 1.956 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 1.991 |
| April 22, 2024 | 1.906 |
| April 19, 2024 | 1.738 |
| April 18, 2024 | 1.850 |
| April 17, 2024 | 1.892 |
| April 16, 2024 | 2.089 |
| April 15, 2024 | 2.201 |
| April 12, 2024 | 2.341 |
| April 11, 2024 | 2.215 |
| April 10, 2024 | 1.808 |
| April 09, 2024 | 1.752 |
| April 08, 2024 | 1.836 |
| April 05, 2024 | 1.850 |
| April 04, 2024 | 1.850 |
| April 03, 2024 | 1.458 |
| April 02, 2024 | 1.332 |
| April 01, 2024 | 1.267 |
| March 28, 2024 | 1.310 |
| March 27, 2024 | 1.241 |
| March 26, 2024 | 1.262 |
| March 25, 2024 | 1.245 |
| March 22, 2024 | 1.280 |
| March 21, 2024 | 1.258 |
| March 20, 2024 | 1.262 |
| March 19, 2024 | 1.217 |
| Date | Value |
|---|---|
| March 18, 2024 | 1.192 |
| March 15, 2024 | 1.206 |
| March 14, 2024 | 1.206 |
| March 13, 2024 | 1.192 |
| March 12, 2024 | 1.248 |
| March 11, 2024 | 1.166 |
| March 08, 2024 | 1.274 |
| March 07, 2024 | 1.340 |
| March 06, 2024 | 1.276 |
| March 05, 2024 | 1.239 |
| March 04, 2024 | 1.262 |
| March 01, 2024 | 1.093 |
| February 29, 2024 | 0.9953 |
| February 28, 2024 | 1.009 |
| February 27, 2024 | 1.051 |
| February 26, 2024 | 0.9789 |
| February 23, 2024 | 0.997 |
| February 22, 2024 | 0.9658 |
| February 21, 2024 | 1.008 |
| February 20, 2024 | 0.9696 |
| February 16, 2024 | 1.040 |
| February 15, 2024 | 1.081 |
| February 14, 2024 | 1.125 |
| February 13, 2024 | 0.957 |
| February 12, 2024 | 1.040 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3283
Minimum
Mar 30 2023
4.306
Maximum
Feb 17 2021
2.186
Average
2.405
Median
Sep 29 2020
Price to Book Value Benchmarks
| Stereotaxis Inc | 12.01 |
| Vanda Pharmaceuticals Inc | 0.4820 |
| Cara Therapeutics Inc | 0.6489 |
| Marinus Pharmaceuticals Inc | 4.718 |
| DiaMedica Therapeutics Inc | 1.829 |
Price to Book Value Related Metrics
| PS Ratio | 2.941 |
| Price | 1.38 |
| Earnings Yield | -104.7% |
| Market Cap | 253.39M |